Ghost Tree Capital, LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ghost Tree Capital, LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$12,125,000
-42.1%
1,250,000
-35.9%
3.33%
-32.3%
Q1 2021$20,943,000
-27.0%
1,950,0000.0%4.92%
-23.0%
Q4 2020$28,685,000
+3.5%
1,950,0000.0%6.39%
-20.2%
Q3 2020$27,710,000
+124.6%
1,950,000
+27.9%
8.01%
+146.1%
Q2 2020$12,337,000
+270.1%
1,525,000
+84.8%
3.26%
+268.2%
Q1 2020$3,333,000825,0000.88%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
AWM Investment Company, Inc. 701,138$4,067,0000.67%
Matrix Capital Management Company, LP 2,288,560$13,274,0000.33%
NEA Management Company, LLC 1,250,000$7,250,0000.31%
Stanley-Laman Group, Ltd. 139,403$809,0000.20%
Cormorant Asset Management, LP 500,000$2,900,0000.19%
Tekla Capital Management LLC 468,399$2,717,0000.10%
Wealth Alliance Advisory Group, LLC 21,800$126,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 175,339$1,007,0000.03%
Artal Group S.A. 150,000$870,0000.02%
Baker Brothers Advisors 505,262$2,931,0000.02%
View complete list of TRILLIUM THERAPEUTICS INC shareholders